Status:
APPROVED_FOR_MARKETING
Compassionate Use of Evinacumab
Lead Sponsor:
Regeneron Pharmaceuticals
Conditions:
Pediatric Homozygous Familial Hypercholesterolemia (HoFH)
Severe Hypertriglyceridemia (HTG)
Brief Summary
Provide compassionate use of evinacumab
Detailed Description
Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications. Availability will depend on location.
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06500598
Last Update
October 28 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.